IP Library Granted Patent US 8,211,172
Granted Patent B2
US 8,211,172 · App. 12/971,125 · Granted Jul 3, 2012

Correction of higher order aberrations in intraocular lenses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,211,172
App. No.
12/971,125
Granted
Jul 3, 2012
Kind
B2
Abstract

In one aspect, the present invention provides a method of designing an intraocular lens (IOL) to address variations of at least one ocular parameter in a population of patient eyes. The method can include establishing at least one eye model in which the ocular parameter can be varied over a range exhibited by the population. The eye model can be employed to evaluate a plurality of IOL designs in correcting visual acuity for eyes in the patient population. An IOL design that provides a best fit for visual performance over at least a portion of the parameter range can then be selected.

Claims (20)

1. A method of manufacturing an ophthalmic lens, comprising

establishing a model eye that incorporates a plurality of ophthalmic lens designs,

determining a modulation transfer function (MTF) at a retinal plane of said model eye,

utilizing at least one MTF value corresponding to a low spatial frequency to evaluate a contrast sensitivity of said model eye;

selecting the ophthalmic lens design with the highest contrast sensitivity; and

manufacturing at least one ophthalmic lens according to the selected ophthalmic lens design.

2. The method of claim 1 , wherein said low spatial frequency is less than about 60 lp/mm (˜18 cycles/degree).

3. The method of claim 2 , wherein said low spatial frequency lies in a range of about 5 to about 60 lp/mm (˜1.5 to 18 cycles/degree).

4. The method of claim 1 , further comprising utilizing at least one MTF value corresponding to a high spatial frequency to evaluate visual acuity of said model eye.

5. The method of claim 4 , wherein said high spatial frequency is greater than about 60 lp/mm (˜18 cycles/degree).

6. The method of claim 5 , wherein said high spatial frequency is in a range of about 60 to about 100 lp/mm (˜18 to 30 cycles/degree).

7. The method of claim 1 , wherein said ophthalmic lens comprises an intraocular lens.

8. A method of manufacturing an ophthalmic lens, comprising

establishing a model eye that incorporates a plurality of ophthalmic lens designs,

determining a modulation transfer function (MTF) at a retinal plane of the model eye,

utilizing at least one MTF value corresponding to a high spatial frequency to evaluate a visual acuity of said model eye,

selecting the ophthalmic lens design with the highest visual acuity; and

manufacturing at least one ophthalmic lens according to the selected ophthalmic lens design.

9. The method of claim 8 , wherein said high spatial frequency is greater than about 60 lp/mm (˜18 cycles/degree).

10. The method of claim 9 , wherein said high spatial frequency is in a range of about 60 to about 100 lp/mm (˜18 to 30 cycles/degree).

Assignments (1)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →